These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12517495)

  • 41. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapy and clinical trials.
    Elkeles RS
    Curr Opin Lipidol; 1998 Feb; 9(1):77-9. PubMed ID: 9502341
    [No Abstract]   [Full Text] [Related]  

  • 43. Low density lipoprotein cholesterol: is lower better?
    Leiter LA
    Can J Cardiol; 2000 Jan; 16 Suppl A():20A-2A. PubMed ID: 10653927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addressing the spectrum of hypercholesterolemia.
    Grundy SM; Mazzaferri EL
    Hosp Pract (1995); 1996 Jun; 31(6):43-8, 53-5, 59; discussion 60. PubMed ID: 8675545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypercholesterolemia in children.
    Shamir R; Lerner A; Fisher EA
    Isr Med Assoc J; 2000 Oct; 2(10):767-71. PubMed ID: 11344730
    [No Abstract]   [Full Text] [Related]  

  • 47. Cost implications of lipid-lowering treatments.
    Reckless JP
    Pharmacoeconomics; 1994 Oct; 6(4):310-23. PubMed ID: 10147467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of coronary heart disease with pravastatin.
    Samani NJ; de Bono DP
    N Engl J Med; 1996 May; 334(20):1333-4; author reply 1334-5. PubMed ID: 8609957
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug treatment for hypercholesterolaemia.
    Ball MJ; Mann JI
    Q J Med; 1986 Aug; 60(232):733-5. PubMed ID: 3774956
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of coronary heart disease with pravastatin.
    Rogers S
    N Engl J Med; 1996 May; 334(20):1333; author reply 1334-5. PubMed ID: 8609956
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coronary risk assessment methods and cholesterol lowering.
    Tang JL; Dickinson JA; Liu JL
    Lancet; 1999 Mar; 353(9158):1095-6; author reply 1096-7. PubMed ID: 10199370
    [No Abstract]   [Full Text] [Related]  

  • 53. The paradox of cholesterol and stroke.
    Amarenco P; Steg PG
    Lancet; 2007 Dec; 370(9602):1803-4. PubMed ID: 18061038
    [No Abstract]   [Full Text] [Related]  

  • 54. [Heart magnyl or statins?].
    Astrup P; Gyntelberg F
    Ugeskr Laeger; 1998 Dec; 160(51):7455. PubMed ID: 9889668
    [No Abstract]   [Full Text] [Related]  

  • 55. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 56. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 57. [Prevention of cardiovascular diseases in elderly subjects with hypercholesterolemia].
    Bruckert E; Giral P
    Therapie; 2000; 55(6):669-74. PubMed ID: 11234461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical inquiries. What levels of cholesterol should be treated for primary prevention?
    Seaton TL; Meadows S
    J Fam Pract; 2002 May; 51(5):423. PubMed ID: 12019047
    [No Abstract]   [Full Text] [Related]  

  • 59. Cholesterol hypothesis vindicated by simvastatin study. Why did it take so long?
    Beamish RE; Dhalla NS
    Can J Cardiol; 1995 Mar; 11(3):191-2. PubMed ID: 7889435
    [No Abstract]   [Full Text] [Related]  

  • 60. [The continuing debate on the treatment of hypercholesterolemia in the primary prevention of coronary disease. What did cholesterol do to deserve that?].
    Ros Rahola E
    Med Clin (Barc); 1997 Oct; 109(14):542-5. PubMed ID: 9508615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.